Ameren (NYSE:AEE – Get Free Report) was downgraded by analysts at Barclays from an “overweight” rating to an “equal weight” rating in a research note issued on Monday,Briefing.com Automated Import reports. They currently have a $95.00 price objective on the utilities provider’s stock, up from their prior price objective of $88.00. Barclays‘s price target points to a potential upside of 0.85% from the stock’s previous close.
Other equities analysts have also issued research reports about the company. BMO Capital Markets increased their price target on Ameren from $93.00 to $98.00 and gave the company an “outperform” rating in a research report on Thursday, December 5th. Evercore ISI upgraded shares of Ameren from an “in-line” rating to an “outperform” rating and boosted their price target for the company from $89.00 to $104.00 in a report on Tuesday, January 21st. Finally, Morgan Stanley raised their price objective on shares of Ameren from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research note on Friday, December 13th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $92.00.
Read Our Latest Stock Report on Ameren
Ameren Price Performance
Insider Buying and Selling at Ameren
In other news, CFO Michael L. Moehn sold 6,500 shares of the stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $92.15, for a total transaction of $598,975.00. Following the transaction, the chief financial officer now owns 205,171 shares in the company, valued at $18,906,507.65. This represents a 3.07 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.42% of the company’s stock.
Institutional Investors Weigh In On Ameren
A number of large investors have recently bought and sold shares of AEE. International Assets Investment Management LLC boosted its position in Ameren by 8,645.7% during the third quarter. International Assets Investment Management LLC now owns 1,160,998 shares of the utilities provider’s stock worth $1,015,410,000 after purchasing an additional 1,147,723 shares during the period. FMR LLC boosted its holdings in shares of Ameren by 59.8% during the 3rd quarter. FMR LLC now owns 2,631,580 shares of the utilities provider’s stock worth $230,158,000 after buying an additional 984,879 shares during the period. Assenagon Asset Management S.A. grew its stake in Ameren by 3,738.0% in the 3rd quarter. Assenagon Asset Management S.A. now owns 745,872 shares of the utilities provider’s stock valued at $65,234,000 after buying an additional 726,438 shares during the last quarter. Verition Fund Management LLC grew its stake in Ameren by 484.8% in the 3rd quarter. Verition Fund Management LLC now owns 637,241 shares of the utilities provider’s stock valued at $55,733,000 after buying an additional 528,270 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec raised its holdings in Ameren by 26.1% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 2,318,537 shares of the utilities provider’s stock worth $202,779,000 after acquiring an additional 479,668 shares during the period. 79.09% of the stock is currently owned by institutional investors.
Ameren Company Profile
Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. The company operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. It engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution business.
Recommended Stories
- Five stocks we like better than Ameren
- How to Invest in the FAANG Stocks
- D-Wave: Recent Updates Propel Shares Off 2025 Lows
- How to trade using analyst ratings
- Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound
- How to Invest in the Best Canadian StocksĀ
- How the $500 Billion Stargate Investment Can Boost These Stocks
Receive News & Ratings for Ameren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ameren and related companies with MarketBeat.com's FREE daily email newsletter.